Hologic Finds Focal Point in Breast Health with New Acquisition

Hologic has signed an agreement to acquire Focal Therapeutics for about $125 million in cash to boost its breast health offerings. The deal comes hot on the heels of the Marlborough, MA-based company announcing it would acquire Faxitron Bioptics, another breast health specialist, for $85 million. Hologic said the Focal acquisition is set to close in early October.